HCC Education and Protocols to Advance Treatment through Integrated Collaboration (HEPATIC)

You must have an ACCC account in order to register for this course/webinar/webinar series [specify].

If You DO NOT Have An ACCC Account:

  • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
    • ACCC members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page, where you can view and update your information.
    • OSS at ACCC Members: Please use your state society login credentials.
    • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page, where you can view and update your information. Click “Change” to add your Areas of Concentration, then save your information.
  • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
  • The green box in the upper right corner of this page will indicate “You are registered!” for this course. Congratulations!

If You Have An ACCC Account:

  • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
  • You will be automatically redirected back to this course/webinar <specify> page, and the green box in the upper right corner will say that “You are registered!” for this course. Congratulations!

PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!

For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar.

Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this course/webinar <specify>. For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

Learn about advanced hepatocellular carcinoma treatments from two leading experts in this case-based activity.

Adam Burgoyne, MD, PhD

Associate Clinical Professor, Department of Medicine

University of California, San Diego

Adam Burgoyne, MD, PhD, is a board-certified medical oncologist who specializes in diagnosing and treating primary liver cancers such as hepatocellular carcinoma (HCC). He also treats cancers of the esophagus, gallbladder, pancreas, stomach, small intestine, colon and appendix, as well as gastrointestinal stromal tumors (GIST).

Dr. Burgoyne uses many forms of therapy, including traditional chemotherapy, immunotherapy and targeted therapy, with an emphasis on personalized medicine, to offer the best possible patient outcomes. Dr. Burgoyne is the medical oncologist for UC San Diego Health's multidisciplinary liver cancer clinic. The clinic offers patients highly specialized and coordinated care at one convenient location, ensuring easy and timely access to the best cancer doctors and the most innovative treatment approaches.

As a physician-scientist, Dr. Burgoyne also leads original research to improve survival rates among people with primary liver cancer and other cancers affecting the digestive system. In particular, he is working on developing novel drugs that inhibit multiple targets within the cancer cell with a single agent. He also studies tumor genetics and the biology of gastrointestinal stromal tumors (GIST) to facilitate personalize cancer care. His work has appeared in Journal of Translational MedicineMolecular Cancer Therapeutics, and Cancer, among others.

Dr. Burgoyne completed a fellowship in hematology and oncology at UC San Diego School of Medicine, where he was chief fellow. He also completed a residency in internal medicine at UC San Diego School of Medicine. Dr. Burgoyne earned his medical degree and doctorate from Case Western Reserve University School of Medicine in Cleveland, Ohio. He is board-certified in internal medicine and medical oncology.

Dr. Burgoyne is a member of the American Association for Cancer Research, the American Association for the Study of Liver Diseases, the American Society of Hematology, and the American Society of Clinical Oncology. He is a member of the Alpha Omega Alpha Honor Medical Society.

Stacey Stein, MD

Associate Professor of Internal Medicine (Medical Oncology); Assistant Medical Director, Clinical Trials Office

Yale Medicine

I take care of patients with advanced liver cancer and offer chemotherapy. I help educate my patients and their families about their cancer and liver disease. Treatment plans often include a pill form of targeted therapy. There are also immune therapy clinical trials available for patients. I work closely with patients to manage their cancer and liver disease related symptoms.


Begin self-paced component package.
Begin self-paced component package.